The majority of human melanomas contain mutations in a gene promoter, suggesting mutations in regulatory regions may spur some cancers.
The majority of human melanomas contain mutations in a gene promoter, suggesting mutations in regulatory regions may spur some cancers.
Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.
Vesicles released by melanoma cells stimulate pro-metastasis behaviors in bone marrow cells.
Starvation paired with cancer drugs slowed or stopped unchecked cell growth in yeast and mouse models of cancer, outpacing or matching the isolated effects of chemo.
Lloyd Old, a researcher and former administrator of two cancer research institutes, passed away this week.
Nanotechnology will offer doctors new ways to diagnose and treat patients, boosting efficiency and slashing costs.
A slew of recent studies sheds light on the neurodegenerative disorder
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
New technologies and mind-sets are required for information delivery in the age of genomics.